Extractions

One row per ingestion event — the raw audit log of every thread the agent processed.

9 rows
IDSaved atProgramVendorServiceThread subjectMessagesLast messageSummary
850a1ab22026-05-13 18:58:50Zcert1profluentFwd: Potential Payload Design Partnership for a CERT1 patient case (neuro, rare disease)2Nome reached out to Profluent about a potential payload design partnership for an N-of-1 CERT1 / CerTra syndrome neuro case, citing Proflue…
d882b6232026-05-13 18:58:07Zsyngap1primara-pharma-partnersRe: Introduction and Survey for Initial Regulatory Assessment (SYNGAP1)2PrimeRA Pharma Partners has been engaged to deliver an Initial Regulatory Assessment for Nome's SYNGAP1 n-of-1 ASO program (two splice-swit…
1b658dc92026-05-13 18:55:28Zcert1tacitFwd: Stevie (Nome) <> David (Tacit)3Nome was introduced to Tacit Therapeutics by Adrian Veres (Dyno) to evaluate RNA trans-splicing as a potentially safer payload for a CERT1 …
921fce682026-05-13 18:41:26Zsyngap1axolabsFwd: RFPs for 2 SYNGAP1 programs - Nome therapeutics <>Axolabs2Nome Therapeutics is engaging Axolabs (LGC Group) to design and screen ASOs against two intronic splice-altering SYNGAP1 variants (c.3583-9…
ecfc8fa32026-05-13 18:40:46Zrho-programcd-genomicsFwd: Long-read Sequencing for Haplotype Phasing - CD Genomics Long-Read Sequencing (ID: M-ING-260320195209)3CD Genomics is engaged to perform long-read PacBio HiFi WGS with haplotype phasing for a rare-disease patient family at Nome. After initial…
049fbfea2026-05-13 18:40:16Zsyngap1evotecFwd: SYNGAP1 programs - Nome3Nome sent Evotec two RFPs for splice-modulating ASO programs targeting SYNGAP1 c.3583-9G>A (iPSC line available) and c.3583-6G>A (no iPSC l…
90d976852026-05-13 18:39:31Zrho-programgenscriptRe: GenScript//Nome Therapeutics (Apurva): Stable Cell Line Generaton Service * CRM:01180024432GenScript is being evaluated for generating two stable HEK293 cell lines overexpressing RHO WT and the c.647T>A mutant to support allele-sp…
c1c7af672026-05-13 18:39:05Zrho-programevotecRe: ASO Project for RHO program1Nome is engaging Evotec to scope an ASO (antisense oligonucleotide) project for the RHO program. Evotec sent over proposal EVT107482 v1 in …
209360e12026-05-13 18:37:59Zcert1editpepFwd: Inquiry from Nome re: Editpep tech2This thread is purely logistical coordination between Nome and Editpep to meet in person at what appears to be a conference, with no substa…